TD Asset Management Inc Cuts Stock Holdings in Stryker Corporation $SYK

Key Points

• TD Asset Management reduced its Stryker stake by 57.4% in the second quarter, selling 335,655 shares and retaining 249,556 shares valued at approximately $78.6 million. Institutional investors collectively own 77.09% of SYK.
• Stryker reported quarterly earnings of $3.69 per share, exceeding the $3.49 consensus estimate, while revenue rose 9.4% year over year to $6.59 billion. The company issued fiscal 2026 EPS guidance of $14.95 to $15.10.
• Analysts maintain a generally positive view, with a consensus rating of “Moderate Buy” and an average price target of $386.28. Stryker also declared a quarterly dividend of $0.88 per share, representing a 1.0% annualized yield.

TD Asset Management Inc cut its position in Stryker Corporation (NYSE:SYK - Free Report) by 57.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 249,556 shares of the medical technology company's stock after selling 335,655 shares during the period. TD Asset Management Inc owned 0.07% of Stryker worth $78,570,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in SYK. Norges Bank acquired a new stake in Stryker during the 4th quarter worth $1,822,272,000. Auto Owners Insurance Co lifted its stake in shares of Stryker by 35,047.0% in the fourth quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company's stock worth $1,024,444,000 after buying an additional 2,906,448 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of Stryker by 22.6% in the fourth quarter. Wellington Management Group LLP now owns 6,493,276 shares of the medical technology company's stock worth $2,282,192,000 after buying an additional 1,198,665 shares in the last quarter. Corient Private Wealth LLC boosted its position in Stryker by 104.4% during the second quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company's stock worth $887,525,000 after acquiring an additional 1,146,998 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its stake in Stryker by 241.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,555,638 shares of the medical technology company's stock valued at $511,167,000 after acquiring an additional 1,100,673 shares in the last quarter. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 310,000 shares of the stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total value of $96,791,300.00. Following the sale, the director owned 1,924,880 shares of the company's stock, valued at $601,005,282.40. This trade represents a 13.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Robert S. Fletcher sold 4,544 shares of Stryker stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total value of $1,394,417.28. Following the completion of the transaction, the vice president owned 10,582 shares of the company's stock, valued at $3,247,298.34. The trade was a 30.04% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on SYK. Barclays lowered their target price on Stryker from $469.00 to $394.00 and set an "overweight" rating on the stock in a report on Monday, May 4th. UBS Group began coverage on Stryker in a research note on Tuesday, July 28th. They issued a "buy" rating and a $400.00 target price for the company. Wells Fargo & Company lowered their price target on shares of Stryker from $456.00 to $418.00 and set an "overweight" rating on the stock in a research report on Friday, May 1st. Sanford C. Bernstein set a $410.00 target price on shares of Stryker in a research note on Friday, May 1st. Finally, Argus set a $370.00 price target on shares of Stryker in a research note on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Stryker presently has an average rating of "Moderate Buy" and a consensus price target of $386.28.

Stryker Stock Performance

Shares of SYK stock opened at $338.80 on Friday. The firm has a 50 day moving average of $324.61 and a two-hundred day moving average of $333.57. The stock has a market capitalization of $129.95 billion, a PE ratio of 35.11, a P/E/G ratio of 2.17 and a beta of 0.76. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. Stryker Corporation has a 52 week low of $281.00 and a 52 week high of $396.86.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, topping analysts' consensus estimates of $3.49 by $0.20. The business had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The company's revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, research analysts predict that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.0%. Stryker's dividend payout ratio is 36.48%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source